Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery Leader?
2025-11-18 10:14:34 ET
Company Background
Founded in 2013 in Salt Lake City, Utah, Recursion Pharmaceuticals, Inc. ( RXRX ) is in the business of using artificial intelligence to expedite new drug discovery. Traditionally, the process of finding and developing new medicines has been one characterized by trial-and-error approaches, which take time and are often costly. From start to finish, the process involves several steps: identifying a target for treatment, like a specific molecule that can be altered or impacted to treat an illness; testing thousands of chemicals to see which ones impact the target molecule in the way intended; identifying the lead candidates and engaging in pre-clinical trials to test for safety (often using mice or other animals in a lab setting), before – if these tests are deemed safe and have the desired effect – finally doing human trials with a view to eventual approval and commercialization. The process can take several years, if not a decade or more in some cases....
Read the full article on Seeking Alpha
For further details see:
Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery Leader?
NASDAQ: NVS
NVS Trading
0.21% G/L:
$143.67 Last:
906,959 Volume:
$142.47 Open:
